BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 31870764)

  • 21. Down-regulation of Langerhans cell protein kinase C-beta isoenzyme expression in inflammatory and hyperplastic dermatoses.
    Reynolds NJ; Yi JY; Fisher GJ; Cooper KD; Voorhees JJ; Griffiths CE
    Br J Dermatol; 1995 Aug; 133(2):157-67. PubMed ID: 7547380
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IL-4 Downregulates IL-1β and IL-6 and Induces GATA3 in Psoriatic Epidermal Cells: Route of Action of a Th2 Cytokine.
    Onderdijk AJ; Baerveldt EM; Kurek D; Kant M; Florencia EF; Debets R; Prens EP
    J Immunol; 2015 Aug; 195(4):1744-52. PubMed ID: 26170379
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sequential BMP7/TGF-β1 signaling and microbiota instruct mucosal Langerhans cell differentiation.
    Capucha T; Koren N; Nassar M; Heyman O; Nir T; Levy M; Zilberman-Schapira G; Zelentova K; Eli-Berchoer L; Zenke M; Hieronymus T; Wilensky A; Bercovier H; Elinav E; Clausen BE; Hovav AH
    J Exp Med; 2018 Feb; 215(2):481-500. PubMed ID: 29343501
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Podoplanin expression in wound and hyperproliferative psoriatic epidermis: regulation by TGF-β and STAT-3 activating cytokines, IFN-γ, IL-6, and IL-22.
    Honma M; Minami-Hori M; Takahashi H; Iizuka H
    J Dermatol Sci; 2012 Feb; 65(2):134-40. PubMed ID: 22189341
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of Langerhans cells in epidermal homeostasis and pathogenesis of psoriasis.
    Yan B; Liu N; Li J; Li J; Zhu W; Kuang Y; Chen X; Peng C
    J Cell Mol Med; 2020 Oct; 24(20):11646-11655. PubMed ID: 32916775
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impaired Langerhans cell migration in psoriasis is due to an altered keratinocyte phenotype induced by interleukin-17.
    Eaton LH; Mellody KT; Pilkington SM; Dearman RJ; Kimber I; Griffiths CEM
    Br J Dermatol; 2018 Jun; 178(6):1364-1372. PubMed ID: 29194565
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of involucrin in psoriatic epidermal keratinocytes: the roles of ERK1/2 and GSK-3β.
    Chen JQ; Man XY; Li W; Zhou J; Landeck L; Cai SQ; Zheng M
    Cell Biochem Biophys; 2013 Jul; 66(3):523-8. PubMed ID: 23283814
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mitogen- and stress-activated protein kinase 1 is activated in lesional psoriatic epidermis and regulates the expression of pro-inflammatory cytokines.
    Funding AT; Johansen C; Kragballe K; Otkjaer K; Jensen UB; Madsen MW; Fjording MS; Finnemann J; Skak-Nielsen T; Paludan SR; Iversen L
    J Invest Dermatol; 2006 Aug; 126(8):1784-91. PubMed ID: 16543895
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preferential expression of alphaEbeta7 integrin (CD103) on CD8+ T cells in the psoriatic epidermis: regulation by interleukins 4 and 12 and transforming growth factor-beta.
    Teraki Y; Shiohara T
    Br J Dermatol; 2002 Dec; 147(6):1118-26. PubMed ID: 12452860
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antigen-presenting cells in essential fatty acid-deficient murine epidermis: keratinocytes bearing class II (Ia) antigens may potentiate the accessory cell function of Langerhans cells.
    Udey MC; Peck RD; Pentland AP; Schreiner GF; Lefkowith JB
    J Invest Dermatol; 1991 Jun; 96(6):950-8. PubMed ID: 1828477
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bone morphogenetic protein-7 represses hepatic stellate cell activation and liver fibrosis
    Zou GL; Zuo S; Lu S; Hu RH; Lu YY; Yang J; Deng KS; Wu YT; Mu M; Zhu JJ; Zeng JZ; Zhang BF; Wu X; Zhao XK; Li HY
    World J Gastroenterol; 2019 Aug; 25(30):4222-4234. PubMed ID: 31435175
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Resident skin cells in psoriasis: a special look at the pathogenetic functions of keratinocytes.
    Albanesi C; De Pità O; Girolomoni G
    Clin Dermatol; 2007; 25(6):581-8. PubMed ID: 18021896
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TGF-beta is required to maintain the pool of immature Langerhans cells in the epidermis.
    Kel JM; Girard-Madoux MJ; Reizis B; Clausen BE
    J Immunol; 2010 Sep; 185(6):3248-55. PubMed ID: 20713882
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The tumour necrosis factor-alpha inhibitor adalimumab rapidly reverses the decrease in epidermal Langerhans cell density in psoriatic plaques.
    Gordon KB; Bonish BK; Patel T; Leonardi CL; Nickoloff BJ
    Br J Dermatol; 2005 Nov; 153(5):945-53. PubMed ID: 16225604
    [TBL] [Abstract][Full Text] [Related]  

  • 35. RAC1 activation drives pathologic interactions between the epidermis and immune cells.
    Winge MC; Ohyama B; Dey CN; Boxer LM; Li W; Ehsani-Chimeh N; Truong AK; Wu D; Armstrong AW; Makino T; Davidson M; Starcevic D; Kislat A; Nguyen NT; Hashimoto T; Homey B; Khavari PA; Bradley M; Waterman EA; Marinkovich MP
    J Clin Invest; 2016 Jul; 126(7):2661-77. PubMed ID: 27294528
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of neutrophils in induction of acute inflammation in T-cell-mediated immune dermatosis, psoriasis: a neutrophil-associated inflammation-boosting loop.
    Terui T; Ozawa M; Tagami H
    Exp Dermatol; 2000 Feb; 9(1):1-10. PubMed ID: 10688368
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tacrolimus and TGF-beta act synergistically on the generation of Langerhans cells.
    Kwiek B; Peng WM; Allam JP; Langner A; Bieber T; Novak N
    J Allergy Clin Immunol; 2008 Jul; 122(1):126-32, 132.e1. PubMed ID: 18547634
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanisms of cyclosporine A inhibition of antigen-presenting activity in uninvolved and lesional psoriatic epidermis.
    Cooper KD; Baadsgaard O; Ellis CN; Duell E; Voorhees JJ
    J Invest Dermatol; 1990 May; 94(5):649-56. PubMed ID: 2324521
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Niche rather than origin dysregulates mucosal Langerhans cells development in aged mice.
    Horev Y; Salameh R; Nassar M; Capucha T; Saba Y; Barel O; Zubeidat K; Matanes D; Leibovich A; Heyman O; Eli-Berchoer L; Hanhan S; Betser-Cohen G; Shapiro H; Elinav E; Bercovier H; Wilensky A; Hovav AH
    Mucosal Immunol; 2020 Sep; 13(5):767-776. PubMed ID: 32457449
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In psoriasis lesional skin the type I interferon signaling pathway is activated, whereas interferon-alpha sensitivity is unaltered.
    van der Fits L; van der Wel LI; Laman JD; Prens EP; Verschuren MC
    J Invest Dermatol; 2004 Jan; 122(1):51-60. PubMed ID: 14962089
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.